Annual Net Income
-$162.86 M
-$16.46 M-11.24%
December 31, 2024
Summary
- As of March 14, 2025, ABCL annual net profit is -$162.86 million, with the most recent change of -$16.46 million (-11.24%) on December 31, 2024.
- During the last 3 years, ABCL annual net income has fallen by -$316.32 million (-206.12%).
- ABCL annual net income is now -202.74% below its all-time high of $158.52 million, reached on December 31, 2022.
Performance
ABCL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$34.21 M
+$16.90 M+33.06%
December 31, 2024
Summary
- As of March 14, 2025, ABCL quarterly net profit is -$34.21 million, with the most recent change of +$16.90 million (+33.06%) on December 31, 2024.
- Over the past year, ABCL quarterly net income has increased by +$16.90 million (+33.06%).
- ABCL quarterly net income is now -120.29% below its all-time high of $168.57 million, reached on March 31, 2022.
Performance
ABCL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$162.86 M
+$12.94 M+7.36%
December 31, 2024
Summary
- As of March 14, 2025, ABCL TTM net profit is -$162.86 million, with the most recent change of +$12.94 million (+7.36%) on December 31, 2024.
- Over the past year, ABCL TTM net income has increased by +$12.94 million (+7.36%).
- ABCL TTM net income is now -165.57% below its all-time high of $248.36 million, reached on September 30, 2022.
Performance
ABCL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ABCL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.2% | +33.1% | +7.4% |
| 3 y3 years | -206.1% | +33.1% | +7.4% |
| 5 y5 years | -7265.8% | +33.1% | +7.4% |
ABCL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -202.7% | at low | -120.3% | +33.1% | -165.6% | +7.4% |
| 5 y | 5-year | -202.7% | at low | -120.3% | +33.1% | -165.6% | +7.4% |
| alltime | all time | -202.7% | at low | -120.3% | +33.1% | -165.6% | +7.4% |
AbCellera Biologics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$162.86 M(+11.2%) | -$34.21 M(-33.1%) | -$162.86 M(-7.4%) |
| Sep 2024 | - | -$51.11 M(+38.4%) | -$175.80 M(+14.7%) |
| Jun 2024 | - | -$36.93 M(-9.1%) | -$153.30 M(+4.4%) |
| Mar 2024 | - | -$40.61 M(-13.9%) | -$146.90 M(+0.3%) |
| Dec 2023 | -$146.40 M(-192.4%) | -$47.15 M(+64.8%) | -$146.40 M(+13.4%) |
| Sep 2023 | - | -$28.61 M(-6.3%) | -$129.14 M(+74.7%) |
| Jun 2023 | - | -$30.53 M(-23.9%) | -$73.91 M(+47.3%) |
| Mar 2023 | - | -$40.11 M(+34.2%) | -$50.16 M(-131.6%) |
| Dec 2022 | $158.52 M | -$29.89 M(-212.3%) | $158.52 M(-36.2%) |
| Sep 2022 | - | $26.62 M(-492.4%) | $248.36 M(+24.0%) |
| Jun 2022 | - | -$6.79 M(-104.0%) | $200.36 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $168.57 M(+181.2%) | $204.82 M(+33.5%) |
| Dec 2021 | $153.46 M(+29.1%) | $59.95 M(-380.4%) | $153.47 M(-27.1%) |
| Sep 2021 | - | -$21.38 M(+820.4%) | $210.52 M(-8.2%) |
| Jun 2021 | - | -$2.32 M(-102.0%) | $229.21 M(-3.8%) |
| Mar 2021 | - | $117.22 M(+0.2%) | $238.23 M(+100.3%) |
| Dec 2020 | $118.92 M(-5478.5%) | $117.00 M(-4444.6%) | $118.92 M(>+9900.0%) |
| Sep 2020 | - | -$2.69 M(-140.2%) | $275.70 K(-90.7%) |
| Jun 2020 | - | $6.70 M(-420.3%) | $2.97 M(-179.5%) |
| Mar 2020 | - | -$2.09 M(+27.5%) | -$3.73 M(+127.5%) |
| Dec 2019 | -$2.21 M(-815.5%) | -$1.64 M | -$1.64 M |
| Dec 2018 | $309.00 K | - | - |
FAQ
- What is AbCellera Biologics annual net profit?
- What is the all time high annual net income for AbCellera Biologics?
- What is AbCellera Biologics annual net income year-on-year change?
- What is AbCellera Biologics quarterly net profit?
- What is the all time high quarterly net income for AbCellera Biologics?
- What is AbCellera Biologics quarterly net income year-on-year change?
- What is AbCellera Biologics TTM net profit?
- What is the all time high TTM net income for AbCellera Biologics?
- What is AbCellera Biologics TTM net income year-on-year change?
What is AbCellera Biologics annual net profit?
The current annual net income of ABCL is -$162.86 M
What is the all time high annual net income for AbCellera Biologics?
AbCellera Biologics all-time high annual net profit is $158.52 M
What is AbCellera Biologics annual net income year-on-year change?
Over the past year, ABCL annual net profit has changed by -$16.46 M (-11.24%)
What is AbCellera Biologics quarterly net profit?
The current quarterly net income of ABCL is -$34.21 M
What is the all time high quarterly net income for AbCellera Biologics?
AbCellera Biologics all-time high quarterly net profit is $168.57 M
What is AbCellera Biologics quarterly net income year-on-year change?
Over the past year, ABCL quarterly net profit has changed by +$16.90 M (+33.06%)
What is AbCellera Biologics TTM net profit?
The current TTM net income of ABCL is -$162.86 M
What is the all time high TTM net income for AbCellera Biologics?
AbCellera Biologics all-time high TTM net profit is $248.36 M
What is AbCellera Biologics TTM net income year-on-year change?
Over the past year, ABCL TTM net profit has changed by +$12.94 M (+7.36%)